APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antigen Self Test Nasal

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antigen Self Test Nasal Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026194 pages

Choose your research edition.

Industry ResearchAntigen Self Test Nasal Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Antigen Self Test Nasal Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Antigen Self Test Nasal Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antigen Self Test Nasal Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Antigen Self Test Nasal Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Antigen Self Test Nasal market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antigen Self Test Nasal is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antigen Self Test Nasal is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antigen Self Test Nasal is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antigen Self Test Nasal is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antigen Self Test Nasal include Roche, Watsons, TEST SEA LAB, SD Biosensor, RapiGEN Inc., Rapid Labs Limited, Quidel, Princeton BioMeditech Corporation and Orient Gene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antigen Self Test Nasal market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antigen Self Test Nasal and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antigen Self Test Nasal sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antigen Self Test Nasal market size, projected growth trends, production technologies, key applications, and end-use industries.

Antigen Self Test Nasal Segment by Company

Roche

Watsons

TEST SEA LAB

SD Biosensor

RapiGEN Inc.

Rapid Labs Limited

Quidel

Princeton BioMeditech Corporation

Orient Gene

OraSure Technologies

LumiraDx

InBios

Heathershaws Compounding Pharmacy

Ellume

CTK Biotech

Clip Health

Celltrion

BioTeke Corporation

BGI

BD

Aidian Oy

ACCESS BIO

Abbott

Antigen Self Test Nasal Segment by Type

Colloidal Gold Immunochromatography

Latex Immunochromatography

Fluorescence Immunochromatography

Others

Antigen Self Test Nasal Segment by Application

Hospital

School

Family

Others

Antigen Self Test Nasal Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antigen Self Test Nasal market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antigen Self Test Nasal and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antigen Self Test Nasal.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antigen Self Test Nasal market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antigen Self Test Nasal manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antigen Self Test Nasal in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antigen Self Test Nasal in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antigen Self Test Nasal Industry Trends Table 2. Antigen Self Test Nasal Industry Drivers Table 3. Antigen Self Test Nasal Industry Opportunities and Challenges Table 4. Antigen Self Test Nasal Industry Restraints Table 5. Global Antigen Self Test Nasal Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antigen Self Test Nasal Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antigen Self Test Nasal Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Antigen Self Test Nasal Sales Market Share by Manufacturers Table 9. Global Antigen Self Test Nasal Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Antigen Self Test Nasal Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antigen Self Test Nasal Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antigen Self Test Nasal Manufacturers, Product Type & Application Table 13. Global Antigen Self Test Nasal Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antigen Self Test Nasal by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Colloidal Gold Immunochromatography Table 17. Major Manufacturers of Latex Immunochromatography Table 18. Major Manufacturers of Fluorescence Immunochromatography Table 19. Major Manufacturers of Others Table 20. Global Antigen Self Test Nasal Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Antigen Self Test Nasal Sales by Type (2021-2026) & (k units) Table 22. Global Antigen Self Test Nasal Sales by Type (2027-2032) & (k units) Table 23. Global Antigen Self Test Nasal Sales Market Share by Type (2021-2026) Table 24. Global Antigen Self Test Nasal Sales Market Share by Type (2027-2032) Table 25. Global Antigen Self Test Nasal Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Antigen Self Test Nasal Revenue by Type (2021-2026) & (k units) Table 27. Global Antigen Self Test Nasal Revenue by Type (2027-2032) & (k units) Table 28. Global Antigen Self Test Nasal Revenue Market Share by Type (2021-2026) Table 29. Global Antigen Self Test Nasal Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of School Table 32. Major Manufacturers of Family Table 33. Major Manufacturers of Others Table 34. Global Antigen Self Test Nasal Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Antigen Self Test Nasal Sales by Application (2021-2026) & (k units) Table 36. Global Antigen Self Test Nasal Sales by Application (2027-2032) & (k units) Table 37. Global Antigen Self Test Nasal Sales Market Share by Application (2021-2026) Table 38. Global Antigen Self Test Nasal Sales Market Share by Application (2027-2032) Table 39. Global Antigen Self Test Nasal Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Antigen Self Test Nasal Revenue by Application (2021-2026) & (k units) Table 41. Global Antigen Self Test Nasal Revenue by Application (2027-2032) & (k units) Table 42. Global Antigen Self Test Nasal Revenue Market Share by Application (2021-2026) Table 43. Global Antigen Self Test Nasal Revenue Market Share by Application (2027-2032) Table 44. Global Antigen Self Test Nasal Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Antigen Self Test Nasal Sales by Region (2021-2026) & (k units) Table 46. Global Antigen Self Test Nasal Sales Market Share by Region (2021-2026) Table 47. Global Antigen Self Test Nasal Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Antigen Self Test Nasal Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Antigen Self Test Nasal Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Antigen Self Test Nasal Sales by Country (2021-2026) & (k units) Table 51. North America Antigen Self Test Nasal Sales by Country (2027-2032) & (k units) Table 52. Europe Antigen Self Test Nasal Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Antigen Self Test Nasal Sales by Country (2021-2026) & (k units) Table 54. Europe Antigen Self Test Nasal Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Antigen Self Test Nasal Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Antigen Self Test Nasal Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Antigen Self Test Nasal Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Antigen Self Test Nasal Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Antigen Self Test Nasal Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Antigen Self Test Nasal Sales by Country (2027-2032) & (k units) Table 61. Global Antigen Self Test Nasal Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Antigen Self Test Nasal Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Antigen Self Test Nasal Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Antigen Self Test Nasal Revenue Market Share by Region (2021-2026) Table 65. Global Antigen Self Test Nasal Revenue Market Share by Region (2027-2032) Table 66. Roche Company Information Table 67. Roche Business Overview Table 68. Roche Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Roche Antigen Self Test Nasal Product Portfolio Table 70. Roche Recent Development Table 71. Watsons Company Information Table 72. Watsons Business Overview Table 73. Watsons Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Watsons Antigen Self Test Nasal Product Portfolio Table 75. Watsons Recent Development Table 76. TEST SEA LAB Company Information Table 77. TEST SEA LAB Business Overview Table 78. TEST SEA LAB Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. TEST SEA LAB Antigen Self Test Nasal Product Portfolio Table 80. TEST SEA LAB Recent Development Table 81. SD Biosensor Company Information Table 82. SD Biosensor Business Overview Table 83. SD Biosensor Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. SD Biosensor Antigen Self Test Nasal Product Portfolio Table 85. SD Biosensor Recent Development Table 86. RapiGEN Inc. Company Information Table 87. RapiGEN Inc. Business Overview Table 88. RapiGEN Inc. Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. RapiGEN Inc. Antigen Self Test Nasal Product Portfolio Table 90. RapiGEN Inc. Recent Development Table 91. Rapid Labs Limited Company Information Table 92. Rapid Labs Limited Business Overview Table 93. Rapid Labs Limited Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Rapid Labs Limited Antigen Self Test Nasal Product Portfolio Table 95. Rapid Labs Limited Recent Development Table 96. Quidel Company Information Table 97. Quidel Business Overview Table 98. Quidel Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Quidel Antigen Self Test Nasal Product Portfolio Table 100. Quidel Recent Development Table 101. Princeton BioMeditech Corporation Company Information Table 102. Princeton BioMeditech Corporation Business Overview Table 103. Princeton BioMeditech Corporation Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Princeton BioMeditech Corporation Antigen Self Test Nasal Product Portfolio Table 105. Princeton BioMeditech Corporation Recent Development Table 106. Orient Gene Company Information Table 107. Orient Gene Business Overview Table 108. Orient Gene Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Orient Gene Antigen Self Test Nasal Product Portfolio Table 110. Orient Gene Recent Development Table 111. OraSure Technologies Company Information Table 112. OraSure Technologies Business Overview Table 113. OraSure Technologies Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. OraSure Technologies Antigen Self Test Nasal Product Portfolio Table 115. OraSure Technologies Recent Development Table 116. LumiraDx Company Information Table 117. LumiraDx Business Overview Table 118. LumiraDx Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. LumiraDx Antigen Self Test Nasal Product Portfolio Table 120. LumiraDx Recent Development Table 121. InBios Company Information Table 122. InBios Business Overview Table 123. InBios Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. InBios Antigen Self Test Nasal Product Portfolio Table 125. InBios Recent Development Table 126. Heathershaws Compounding Pharmacy Company Information Table 127. Heathershaws Compounding Pharmacy Business Overview Table 128. Heathershaws Compounding Pharmacy Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Heathershaws Compounding Pharmacy Antigen Self Test Nasal Product Portfolio Table 130. Heathershaws Compounding Pharmacy Recent Development Table 131. Ellume Company Information Table 132. Ellume Business Overview Table 133. Ellume Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Ellume Antigen Self Test Nasal Product Portfolio Table 135. Ellume Recent Development Table 136. CTK Biotech Company Information Table 137. CTK Biotech Business Overview Table 138. CTK Biotech Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. CTK Biotech Antigen Self Test Nasal Product Portfolio Table 140. CTK Biotech Recent Development Table 141. Clip Health Company Information Table 142. Clip Health Business Overview Table 143. Clip Health Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Clip Health Antigen Self Test Nasal Product Portfolio Table 145. Clip Health Recent Development Table 146. Celltrion Company Information Table 147. Celltrion Business Overview Table 148. Celltrion Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Celltrion Antigen Self Test Nasal Product Portfolio Table 150. Celltrion Recent Development Table 151. BioTeke Corporation Company Information Table 152. BioTeke Corporation Business Overview Table 153. BioTeke Corporation Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. BioTeke Corporation Antigen Self Test Nasal Product Portfolio Table 155. BioTeke Corporation Recent Development Table 156. BGI Company Information Table 157. BGI Business Overview Table 158. BGI Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. BGI Antigen Self Test Nasal Product Portfolio Table 160. BGI Recent Development Table 161. BD Company Information Table 162. BD Business Overview Table 163. BD Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. BD Antigen Self Test Nasal Product Portfolio Table 165. BD Recent Development Table 166. Aidian Oy Company Information Table 167. Aidian Oy Business Overview Table 168. Aidian Oy Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. Aidian Oy Antigen Self Test Nasal Product Portfolio Table 170. Aidian Oy Recent Development Table 171. ACCESS BIO Company Information Table 172. ACCESS BIO Business Overview Table 173. ACCESS BIO Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 174. ACCESS BIO Antigen Self Test Nasal Product Portfolio Table 175. ACCESS BIO Recent Development Table 176. Abbott Company Information Table 177. Abbott Business Overview Table 178. Abbott Antigen Self Test Nasal Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 179. Abbott Antigen Self Test Nasal Product Portfolio Table 180. Abbott Recent Development Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Antigen Self Test Nasal Distributors List Table 184. Antigen Self Test Nasal Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Antigen Self Test Nasal Product Image Figure 2. Global Antigen Self Test Nasal Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antigen Self Test Nasal Market Size (2021-2032) & (US$ Million) Figure 4. Global Antigen Self Test Nasal Sales (2021-2032) & (k units) Figure 5. Global Antigen Self Test Nasal Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antigen Self Test Nasal Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Colloidal Gold Immunochromatography Image Figure 9. Latex Immunochromatography Image Figure 10. Fluorescence Immunochromatography Image Figure 11. Others Image Figure 12. Global Antigen Self Test Nasal Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Antigen Self Test Nasal Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Antigen Self Test Nasal Sales Market Share by Type (2021-2032) Figure 15. Global Antigen Self Test Nasal Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Antigen Self Test Nasal Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Antigen Self Test Nasal Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. School Image Figure 20. Family Image Figure 21. Others Image Figure 22. Global Antigen Self Test Nasal Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Antigen Self Test Nasal Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Antigen Self Test Nasal Sales Market Share by Application (2021-2032) Figure 25. Global Antigen Self Test Nasal Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Antigen Self Test Nasal Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Antigen Self Test Nasal Revenue Market Share by Application (2021-2032) Figure 28. North America Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Antigen Self Test Nasal Sales Market Share by Country (2021-2032) Figure 30. U.S. Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Antigen Self Test Nasal Sales Market Share by Country (2021-2032) Figure 35. Germany Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Antigen Self Test Nasal Sales Market Share by Country (2021-2032) Figure 42. China Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Antigen Self Test Nasal Sales Market Share by Country (2021-2032) Figure 50. Brazil Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Antigen Self Test Nasal Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Antigen Self Test Nasal Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Antigen Self Test Nasal Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Antigen Self Test Nasal Revenue (2021-2032) & (US$ Million) Figure 61. North America Antigen Self Test Nasal Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Antigen Self Test Nasal Revenue (2021-2032) & (US$ Million) Figure 63. Europe Antigen Self Test Nasal Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Antigen Self Test Nasal Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Antigen Self Test Nasal Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Antigen Self Test Nasal Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Antigen Self Test Nasal Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Antigen Self Test Nasal Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Antigen Self Test Nasal Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Colloidal Gold Immunochromatography
  • Latex Immunochromatography
  • Fluorescence Immunochromatography
  • Others
Applications
  • Hospital
  • School
  • Family
  • Others
Companies covered
  • Roche
  • Watsons
  • TEST SEA LAB
  • SD Biosensor
  • RapiGEN Inc.
  • Rapid Labs Limited
  • Quidel
  • Princeton BioMeditech Corporation
  • Orient Gene
  • OraSure Technologies
  • LumiraDx
  • InBios
  • Heathershaws Compounding Pharmacy
  • Ellume
  • CTK Biotech
  • Clip Health
  • Celltrion
  • BioTeke Corporation
  • BGI
  • BD
  • Aidian Oy
  • ACCESS BIO
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antigen Self Test Nasal Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antigen Self Test Nasal Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antigen Self Test Nasal Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antigen Self Test Nasal Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antigen Self Test Nasal Market Dynamics
  1. 2.1 Antigen Self Test Nasal Industry Trends
  2. 2.2 Antigen Self Test Nasal Industry Drivers
  3. 2.3 Antigen Self Test Nasal Industry Opportunities and Challenges
  4. 2.4 Antigen Self Test Nasal Industry Restraints
3 Antigen Self Test Nasal Market by Manufacturers
  1. 3.1 Global Antigen Self Test Nasal Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antigen Self Test Nasal Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antigen Self Test Nasal Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antigen Self Test Nasal Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antigen Self Test Nasal Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antigen Self Test Nasal Manufacturers, Product Type & Application
  7. 3.7 Global Antigen Self Test Nasal Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antigen Self Test Nasal Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antigen Self Test Nasal Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antigen Self Test Nasal Tier 1, Tier 2, and Tier 3
4 Antigen Self Test Nasal Market by Type
  1. 4.1 Antigen Self Test Nasal Type Introduction
  2. 4.1.1 Colloidal Gold Immunochromatography
  3. 4.1.2 Latex Immunochromatography
  4. 4.1.3 Fluorescence Immunochromatography
  5. 4.1.4 Others
  6. 4.2 Global Antigen Self Test Nasal Sales by Type
  7. 4.2.1 Global Antigen Self Test Nasal Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Antigen Self Test Nasal Sales by Type (2021-2032)
  9. 4.2.3 Global Antigen Self Test Nasal Sales Market Share by Type (2021-2032)
  10. 4.3 Global Antigen Self Test Nasal Revenue by Type
  11. 4.3.1 Global Antigen Self Test Nasal Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Antigen Self Test Nasal Revenue by Type (2021-2032)
  13. 4.3.3 Global Antigen Self Test Nasal Revenue Market Share by Type (2021-2032)
5 Antigen Self Test Nasal Market by Application
  1. 5.1 Antigen Self Test Nasal Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 School
  4. 5.1.3 Family
  5. 5.1.4 Others
  6. 5.2 Global Antigen Self Test Nasal Sales by Application
  7. 5.2.1 Global Antigen Self Test Nasal Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Antigen Self Test Nasal Sales by Application (2021-2032)
  9. 5.2.3 Global Antigen Self Test Nasal Sales Market Share by Application (2021-2032)
  10. 5.3 Global Antigen Self Test Nasal Revenue by Application
  11. 5.3.1 Global Antigen Self Test Nasal Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Antigen Self Test Nasal Revenue by Application (2021-2032)
  13. 5.3.3 Global Antigen Self Test Nasal Revenue Market Share by Application (2021-2032)
6 Global Antigen Self Test Nasal Sales by Region
  1. 6.1 Global Antigen Self Test Nasal Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antigen Self Test Nasal Sales by Region (2021-2032)
  3. 6.2.1 Global Antigen Self Test Nasal Sales by Region (2021-2026)
  4. 6.2.2 Global Antigen Self Test Nasal Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antigen Self Test Nasal Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antigen Self Test Nasal Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antigen Self Test Nasal Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antigen Self Test Nasal Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antigen Self Test Nasal Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antigen Self Test Nasal Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antigen Self Test Nasal Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antigen Self Test Nasal Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antigen Self Test Nasal Revenue by Region
  1. 7.1 Global Antigen Self Test Nasal Revenue by Region
  2. 7.1.1 Global Antigen Self Test Nasal Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antigen Self Test Nasal Revenue by Region (2021-2026)
  4. 7.1.3 Global Antigen Self Test Nasal Revenue by Region (2027-2032)
  5. 7.1.4 Global Antigen Self Test Nasal Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antigen Self Test Nasal Revenue (2021-2032)
  8. 7.2.2 North America Antigen Self Test Nasal Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antigen Self Test Nasal Revenue (2021-2032)
  11. 7.3.2 Europe Antigen Self Test Nasal Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antigen Self Test Nasal Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antigen Self Test Nasal Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antigen Self Test Nasal Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antigen Self Test Nasal Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Antigen Self Test Nasal Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Watsons
  8. 8.2.1 Watsons Company Information
  9. 8.2.2 Watsons Business Overview
  10. 8.2.3 Watsons Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Watsons Antigen Self Test Nasal Product Portfolio
  12. 8.2.5 Watsons Recent Developments
  13. 8.3 TEST SEA LAB
  14. 8.3.1 TEST SEA LAB Company Information
  15. 8.3.2 TEST SEA LAB Business Overview
  16. 8.3.3 TEST SEA LAB Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 TEST SEA LAB Antigen Self Test Nasal Product Portfolio
  18. 8.3.5 TEST SEA LAB Recent Developments
  19. 8.4 SD Biosensor
  20. 8.4.1 SD Biosensor Company Information
  21. 8.4.2 SD Biosensor Business Overview
  22. 8.4.3 SD Biosensor Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SD Biosensor Antigen Self Test Nasal Product Portfolio
  24. 8.4.5 SD Biosensor Recent Developments
  25. 8.5 RapiGEN Inc.
  26. 8.5.1 RapiGEN Inc. Company Information
  27. 8.5.2 RapiGEN Inc. Business Overview
  28. 8.5.3 RapiGEN Inc. Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 RapiGEN Inc. Antigen Self Test Nasal Product Portfolio
  30. 8.5.5 RapiGEN Inc. Recent Developments
  31. 8.6 Rapid Labs Limited
  32. 8.6.1 Rapid Labs Limited Company Information
  33. 8.6.2 Rapid Labs Limited Business Overview
  34. 8.6.3 Rapid Labs Limited Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Rapid Labs Limited Antigen Self Test Nasal Product Portfolio
  36. 8.6.5 Rapid Labs Limited Recent Developments
  37. 8.7 Quidel
  38. 8.7.1 Quidel Company Information
  39. 8.7.2 Quidel Business Overview
  40. 8.7.3 Quidel Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Quidel Antigen Self Test Nasal Product Portfolio
  42. 8.7.5 Quidel Recent Developments
  43. 8.8 Princeton BioMeditech Corporation
  44. 8.8.1 Princeton BioMeditech Corporation Company Information
  45. 8.8.2 Princeton BioMeditech Corporation Business Overview
  46. 8.8.3 Princeton BioMeditech Corporation Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Princeton BioMeditech Corporation Antigen Self Test Nasal Product Portfolio
  48. 8.8.5 Princeton BioMeditech Corporation Recent Developments
  49. 8.9 Orient Gene
  50. 8.9.1 Orient Gene Company Information
  51. 8.9.2 Orient Gene Business Overview
  52. 8.9.3 Orient Gene Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Orient Gene Antigen Self Test Nasal Product Portfolio
  54. 8.9.5 Orient Gene Recent Developments
  55. 8.10 OraSure Technologies
  56. 8.10.1 OraSure Technologies Company Information
  57. 8.10.2 OraSure Technologies Business Overview
  58. 8.10.3 OraSure Technologies Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 OraSure Technologies Antigen Self Test Nasal Product Portfolio
  60. 8.10.5 OraSure Technologies Recent Developments
  61. 8.11 LumiraDx
  62. 8.11.1 LumiraDx Company Information
  63. 8.11.2 LumiraDx Business Overview
  64. 8.11.3 LumiraDx Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 LumiraDx Antigen Self Test Nasal Product Portfolio
  66. 8.11.5 LumiraDx Recent Developments
  67. 8.12 InBios
  68. 8.12.1 InBios Company Information
  69. 8.12.2 InBios Business Overview
  70. 8.12.3 InBios Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 InBios Antigen Self Test Nasal Product Portfolio
  72. 8.12.5 InBios Recent Developments
  73. 8.13 Heathershaws Compounding Pharmacy
  74. 8.13.1 Heathershaws Compounding Pharmacy Company Information
  75. 8.13.2 Heathershaws Compounding Pharmacy Business Overview
  76. 8.13.3 Heathershaws Compounding Pharmacy Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Heathershaws Compounding Pharmacy Antigen Self Test Nasal Product Portfolio
  78. 8.13.5 Heathershaws Compounding Pharmacy Recent Developments
  79. 8.14 Ellume
  80. 8.14.1 Ellume Company Information
  81. 8.14.2 Ellume Business Overview
  82. 8.14.3 Ellume Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ellume Antigen Self Test Nasal Product Portfolio
  84. 8.14.5 Ellume Recent Developments
  85. 8.15 CTK Biotech
  86. 8.15.1 CTK Biotech Company Information
  87. 8.15.2 CTK Biotech Business Overview
  88. 8.15.3 CTK Biotech Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CTK Biotech Antigen Self Test Nasal Product Portfolio
  90. 8.15.5 CTK Biotech Recent Developments
  91. 8.16 Clip Health
  92. 8.16.1 Clip Health Company Information
  93. 8.16.2 Clip Health Business Overview
  94. 8.16.3 Clip Health Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Clip Health Antigen Self Test Nasal Product Portfolio
  96. 8.16.5 Clip Health Recent Developments
  97. 8.17 Celltrion
  98. 8.17.1 Celltrion Company Information
  99. 8.17.2 Celltrion Business Overview
  100. 8.17.3 Celltrion Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Celltrion Antigen Self Test Nasal Product Portfolio
  102. 8.17.5 Celltrion Recent Developments
  103. 8.18 BioTeke Corporation
  104. 8.18.1 BioTeke Corporation Company Information
  105. 8.18.2 BioTeke Corporation Business Overview
  106. 8.18.3 BioTeke Corporation Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 BioTeke Corporation Antigen Self Test Nasal Product Portfolio
  108. 8.18.5 BioTeke Corporation Recent Developments
  109. 8.19 BGI
  110. 8.19.1 BGI Company Information
  111. 8.19.2 BGI Business Overview
  112. 8.19.3 BGI Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 BGI Antigen Self Test Nasal Product Portfolio
  114. 8.19.5 BGI Recent Developments
  115. 8.20 BD
  116. 8.20.1 BD Company Information
  117. 8.20.2 BD Business Overview
  118. 8.20.3 BD Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 BD Antigen Self Test Nasal Product Portfolio
  120. 8.20.5 BD Recent Developments
  121. 8.21 Aidian Oy
  122. 8.21.1 Aidian Oy Company Information
  123. 8.21.2 Aidian Oy Business Overview
  124. 8.21.3 Aidian Oy Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Aidian Oy Antigen Self Test Nasal Product Portfolio
  126. 8.21.5 Aidian Oy Recent Developments
  127. 8.22 ACCESS BIO
  128. 8.22.1 ACCESS BIO Company Information
  129. 8.22.2 ACCESS BIO Business Overview
  130. 8.22.3 ACCESS BIO Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 ACCESS BIO Antigen Self Test Nasal Product Portfolio
  132. 8.22.5 ACCESS BIO Recent Developments
  133. 8.23 Abbott
  134. 8.23.1 Abbott Company Information
  135. 8.23.2 Abbott Business Overview
  136. 8.23.3 Abbott Antigen Self Test Nasal Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Abbott Antigen Self Test Nasal Product Portfolio
  138. 8.23.5 Abbott Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antigen Self Test Nasal Value Chain Analysis
  2. 9.1.1 Antigen Self Test Nasal Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antigen Self Test Nasal Production Mode & Process
  6. 9.2 Antigen Self Test Nasal Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antigen Self Test Nasal Distributors
  9. 9.2.3 Antigen Self Test Nasal Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst